DOI:

Multifocal arterial fibromuscular dysplasia causing coronary artery dissection following coronary angiography

Jonas de Jong*, MD; Jan Piek, MD, PhD; Allard van der Wal, MD, PhD

A 31 year old man was referred to our hospital for evaluation of recurrent angina pectoris following recent inferior-posterior myocardial infarction. His previous medical history included a surgically corrected tetralogy of Fallot at four years of age. During coronary angiography of the left anterior descending artery, a dissection of the entire vessel developed (Figure 1).

Figure 1 and Movie 1. Acute dissection of the LAD during diagnostic catheterisation.

The dissection could not be crossed with a guidewire and the patient died.

Post mortem examination was performed. Histologically, the LAD dissection channel was filled with fresh haematoma indicating recent onset (Figure 2).

Figure 2. Cross section of the LAD showing a dissection channel in the outer part of the arterial media, filled with haematoma (Mallory’s stain).

The media showed abnormal presence of segmental ridges of medial tissue containing haphazardly arranged smooth muscle layers intermingled with elastin and collagenous tissue (Figure 3).

Figure 3. Detail of the coronary artery wall showing highly irregular medial ridges of fibromuscular tissue characteristic for the medial type of FMD. (Elastica van Gieson stain).

There were no signs of of inflammation (Figures 2 and 3) or previous dissections. These findings were diagnostic for the media type of fibromuscular dysplasia (FMD).

FMD is a segmental non-atherosclerotic non-inflammatory angiopathy of unknown aetiology. Renal and cervicocranial arteries are most commonly involved. Coronary FMD is very rare1. The disease is histologically classified according to the principal layer of arterial involvement (intimal-, medial- and peri-adventitial FMD). Medial FMD as found in our patient is by far (approximately 90% of cases) the commonest type.

Reference

Volume 5 Number 1
May 19, 2009
Volume 5 Number 1
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00453 Jul 6, 2026
AnchorMan versus Watchman 2.5: a randomised comparison in left atrial appendage closure
Garot P and Nielsen-Kudsk J
free

Editorial

10.4244/EIJ-E-26-00011 Jul 6, 2026
Comparing transcatheter aortic valves: time to look beyond simplistic categorisations
Blackman D and Maznyczka A
free

Original Research

10.4244/EIJ-D-26-00158 Jul 6, 2026
Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trial
Fontana G et al

Research Correspondence

10.4244/EIJ-D-26-00315 Jul 6, 2026
Validation of the VARC-HBR consensus for defining high bleeding risk in TAVI
Singh M et al

Research Correspondence

10.4244/EIJ-D-26-00271 Jul 6, 2026
Outcomes of percutaneous mechanical aspiration in left-sided infective endocarditis
Lugo-Fagundo NS et al

Flashlight

10.4244/EIJ-D-26-00128 Jul 6, 2026
Concomitant transfemoral aortic and mitral valve replacement
Lianos I et al
Trending articles
334.7

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
45.75

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
29.2

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
29.2

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved